First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
GlobeNewswire
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the..
BOCA RATON, Fla., April 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the..
*MEDIA RELEASE*
· Wyost^® (denosumab-bddz) and Jubbonti^® (denosumab-bddz) interchangeable with and approved by FDA..
Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX”*THE WOODLANDS, TX., Jan. 26, 2024 (GLOBE..